The mechanistic target of rapamycin (mTOR) is a central regulator of cellular growth, metabolism, and survival, frequently hyperactivated in BC, where it drives tumorigenesis, promotes angiogenesis, and facilitates immune evasion [48]. The gene discussed is MTOR; the disease is breast cancer.